Double blind placebo controlled parallel group comparison of atomoxetine (Strattera) for generalized social anxiety disorder.
Phase of Trial: Phase II/III
Latest Information Update: 26 Jun 2016
At a glance
- Drugs Atomoxetine (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 14 Dec 2008 Primary endpoint changed from Liebowitz Social Anxiety Scale to Clinical Global Impressions Scale as reported by ClinicalTrials.gov.
- 15 Sep 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 15 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.